Tigecycline is a novel glycylcycline antimicrobial for intravenous use. Tigecycline for injection for intravenous use chemical family. Clinical breakpoints fungi candida and aspergillus guidance for organisms not listed in breakpoint tables. Due to tigecycline has shown excellent in vitro activity. The 3month old infant suffered from a catheterassociated bloodstream infection by multiple drug resistant klebsiella pneumoniae.
Hazards identification classification of the substance or. Tigecycline slightly decreased the c max of digoxin by %, but did not affect the auc or. Tigecycline how powerful is it in the fight against antibiotic. Each tigecycline single dose 10 ml vial contains 50 mg tigecycline and 82. Tygacil is not indicated for treatment of diabetic foot infection or hospitalacquired pneumonia, including ventilator associated pneumonia. To assess the efficacy and safety of tigecycline in comparison with other antimicrobial treatments for infectious diseases. Patients with bloodstream infections bsi are associated with high mortality rates. Tigecycline therapy is sometimes accompanied by minor aminotransferase elevations, but has not been definitely associated with clinically apparent liver injury with jaundice. The mean pharmacokinetic parameters of tigecycline after single and multiple intravenous doses based on pooled data from clinical pharmacology studies are. Minimal organ toxicity and lack of dosage adjustment in most patients are important considerations for. The list of antibiotics available for efficient treatment of communityacquired and nosocomial infections caused by methicillinresistant staphylococcus au reus. Prolonged and high dosage of tigecycline successful treatment of. Switch therapy is a management approach combining early discontinuation of. An increase in allcause mortality has been observed across phase 3 and 4 clinical trials in tygaciltreated patients versus comparatortreated patients.
Files are available under licenses specified on their description page. Tigecycline is a parenteral glycycline antibiotic used for treatment of serious infections due to susceptible organisms. Pharmacokinetics of tigecycline after single and multiple. Tigecycline is used to treat many different bacterial infections of the skin or the digestive system. Alternatively, you can download the file locally and open with any standalone pdf reader. An increase was also seen in a metaanalysis limited to the approved indications 0. Tigecycline application in a 3monthold infant with. In particular, tigecycline showed a mic90 value of 2 mgl and our strains displayed a unimodal distribution of. Tigecycline is an immature antibiotic for children. The pdf file you selected should load here if your web browser has a pdf reader plugin installed for example, a recent version of adobe acrobat reader alternatively, you can also download the pdf file directly to your computer, from where it can be opened using a pdf reader. To download the pdf, click the download link below. Tigecycline is active against grampositive and gramnegative bacteria, including tetracyclineresistant organisms, and some anaerobes. Tigecycline evades the tetae efflux pumps, 11,12 which account for most acquired resistance to tetracycline and minocycline in enterobacteriaceae and acinetobacter spp also the tetk pumps, which occur widely in staphylococci conferring resistance to tetracycline though not minocycline or doxycycline. Dailymed tigecycline injection, powder, lyophilized, for.
Tigecycline is a similar to the tetracyclines and may chelate calcium ions and discolor teeth if administered to patients during tooth development pdf file should load here. Each 5 ml tygacil vial contains 50 mg of tigecycline. The pdf file you selected should load here if your web browser has a pdf reader plugin installed for example, a recent version of adobe acrobat reader. Efficacy and safety of tigecycline for the treatment of severe. It has an expanded broadspectrum antibacterial activity including multidrug resistant. Tigecycline is an antibiotic for a number of bacterial infections. Tigecycline is the first member of a new class of broadspectrum antibacterials, the glycylcyclines, that has been specifically developed to overcome the two major mechanisms of tetracycline resistance ribosomal protection and efflux. If you do not see its contents the file may be temporarily unavailable at the journal website or you do not have a pdf plugin installed and enabled in your browser.
See also the eucast aminoglycoside guidance document for the use of the revised aminoglycoside breakpoints. Briefly, the method consisted of protein precipitation of the serum samples by addition of acetonitrile, separation of tigecycline on a supelco lc18 db column 150 by 4. Pharmaceutical product used as antibiotic agent details of the supplier of the safety data sheet 2. We describe a case of sustained and severe hypoglycemia in a patient treated with tigecycline for pneumonia due to mdr klebsiella pneumoniae.
Tigecycline has been considered as one of the few therapeutic. The purpose of this study was to evaluate the effectiveness and safety of the use of tigecycline for the. Tigecycline side effects, dosage, interactions drugs. Tigecycline is the first agent in the new class of glycylcycline antibiotics. Some of the mic values of tigecycline may be higher than recorded values, because tigecycline requires a. If you have any further questions, ask your doctor or nurse. Tigecycline, the first in a new class of antimicrobials, the glycylcyclines, is an analogue.
Healthcareassociatednosocomial infections are increasing and important causes of morbidity after spinal surgery in many countries around the world. Tygacil is contraindicated for use in patients who have known hypersensitivity to tigecycline. Tigecycline wyeth, formerly gar936, was licensed by the usas food and drug administration in june 2005. This article is from bmc infectious diseases, volume 12. Clinical and microbiological characteristics of tigecycline non. Tigecycline is the first glycylcycline to be launched and is one of the very few new antimicrobials with activity against gramnegative bacteria. A critical analysis clinical infectious diseases oxford. Clinical experience with tigecycline in the treatment of. To reduce the development of drugresistant bacteria and maintain the effectiveness of tygacil and other antibacterial drugs, tygacil should be used only to treat or prevent infections that are proven or.
Tigecycline has a large volume of distribution 12 lkg, penetrating well into bone, lung, liver, and kidney tissues. This medicine is only for use when other drugs cannot be used. Tygacil tigecycline dose, indications, adverse effects. Some products have maltose in them, which may affect. The efficacy of the quorum sensing inhibitor fs8 and tigecycline in preventing prosthesis biofilm in an animal model of staphylococcal infection. The efficacy of the quorum sensing inhibitor fs8 and. Exiso gui makes easier to extract multiple iso with a queue list and a little ftp browser. The ph is adjusted with hydrochloric acid, and if necessary sodium hydroxide. It is the first glycylcycline to be launched and the first new tetracycline analogue since minocycline over 30 years ago.
Tigecycline is the first member of the glycylcycline class of antibiotics, modified to have broadspectrum activity against most grampositive and gramnegative, aerobic and anaerobic bacteria. Appropriate use of tigecycline a j brink, d bizos, k d boffard, c feldman, d c grolman, j pretorius, g a richards, m senekal, e steyn, n welkovic 1. If the file has been modified from its original state, some details such as the timestamp may not fully reflect those of the original file. Tigecycline shows higher binding affinity than tetracyclines, being active against bacterial strains with either mechanism of tetracycline resistance efflux and ribosomal protection. The efficacy and safety of tigecycline for the treatment of. We report the youngest surviving patient who received a complete tigecycline treatment, and no significant adverse effects occurred in the patient. This file contains additional information such as exif metadata which may have been added by the digital camera, scanner, or software program used to create or digitize it. Thirdly, this article focused on the efficacy and adverse events of tigecycline, while. Tigecycline 50 mg powder for solution for infusion tigecycline read all of this leaflet carefully before you are given this medicine because it contains important information for you. Alternatively, you can also download the pdf file directly to your computer, from where it can be opened using a pdf reader. Pdf tigecycline is the first food and drug administration fda approved glycylcycline antibiotic. A 74yearold man was admitted for treatment of pneumonia. Eucast instruction video on how to use the breakpoint table download here.
All structured data from the file and property namespaces is available under the creative commons cc0 license. Efficacy of tigecycline monotherapy versus combination. In vitro, tigecycline was active against a wide range of grampositive and negative aerobic and anaerobic bacteria implicated in complicated skin. The purpose of this study was to examine the use of tigecycline in the treatment of prosthetic joint infection pji. Minimum inhibitory concentrations mcgml disk diffusion zone diameter in mm. The efficacy and safety of tigecycline for the treatment. Tigecycline is an antibiotic that fights bacteria in the body. Tigecycline for injection, usp is an orange lyophilized powder or cake. Tigecycline, the first glycylcyclineclass drug, is a broadspectrum antibiotic with activity against multidrug resistant mdr organisms. It has shown remarkable in vitro activity against a wide variety of grampositive, gramnegative. What should i avoid while using tigecycline tygacil.
In the sad and mad studies, tigecycline was assayed in serum by a highperformance liquid chromatography method with calibrators in the range of 25 to 12,500 ngml. Although it is structurally related to minocycline, alterations to the molecule resulted in its expanded spectrum of activity and decreased susceptibility to the development of resistance when compared with other tetracycline antibiotics. In vitro activity of tigecycline and comparators against carbapenem. The cause of this increase has not been established. A larger number of deaths happened in people taking tigecycline compared to people taking other drugs used to treat infections. Tigecycline is a glycylcycline antibiotic derived from the tetracycline group, that acts by inhibiting protein synthesis at the level of the bacterial ribosome.
Tigecycline is the first drug in the glycylcycline class of antibiotics. Tetracycline derivative relevant identified uses of the substance or mixture and uses advised against intended use. Tigecycline is fda approved for treatment of complicated skinskin structure infections, complicated intraabdominal infections, and communityacquired pneumonia. Tygacil 100 mg followed by 50 mg every 12 hours and digoxin 0. As a tetracycline derivative antibiotic, its structural modifications has expanded its therapeutic activity to include gram. Due to tigecycline has shown excellent in vitro activity against most pathogens, tigecycline is selected as one of the candidate drugs for the treatment of multidrugresistant organisms infections. Tigecycline is a broadspectrum antibiotic with activity against difficulttotreat pathogens such as methicillinresistant staphylococcus aureus, vancomycinresistant enterococcus spp. Tigecycline in combination with other antibiotics against.
It is also active against meticillinresistant staphylococcus aureus and vancomycinresistant enterococci, but pseudomonas aeruginosa and many strains of proteus spp are resistant to tigecycline. Risk factors for acquisition of pseudomonas and proteus species during. Introduction tigecycline, the first of a new class of broadspectrum antibiotics, the glycylcyclines, was recently licensed in south africa for the parenteral treatment of adult patients. Resistance among klebsiella pneumoniae to most antibiotics is on the rise. However, because of its extensive distribution into tissue, high blood levels are not maintained, so tigecycline is probably not a good choice for patients with bacteremia. Tigecycline in the management of postneurosurgical spondylodiscitis. Its expanded broad spectrum of activity, with demonstrated efficacy as monotherapy against clinically important grampositive and gramnegative pathogens include also anerobes and antibioticresistant isolates. Persons with disabilities having problems accessing the pdf files below may call 301 7963634 for assistance. A metaanalysis of phase 3 and 4 clinical trials demonstrated an increase in allcause mortality in tigecycline treated patients compared to controls with a risk difference of 0. It was developed in response to the growing rate of antibiotic resistant bacteria such as staphylococcus aureus, acinetobacter baumannii, and e.
238 773 1251 62 587 793 1357 735 1376 841 1450 1011 1294 222 482 1144 840 133 85 482 722 1083 892 1119 1028 1013 178 1024 1381 683 941 199 1060 82 1437 1107 45 95 910 578 907 885 844 529 230 1198